Mutations in the Prophet of Pit-1 (Prop-1), a paired-like homeodomain transcription factor involved in the early embryonic pituitary development, have been reported as a cause of combined hormone deficiency (CPHD) involving growth hormone (GH), prolactin (PRL), thyroid-stimulating hormone (TSH), gonadotrophins and in some cases adrenocorticotrophic hormone (ACTH). We report two pre-pubertal siblings with short stature and deficiency of GH and TSH at presentation. Molecular analysis of the PROP1 gene revealed compound heterozygotes for two novel missense mutations of the PROP1 gene affecting the same amino acid (Arg71Cys and Arg71His) in the first alpha helix of the Prop-1 homeodomain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1034/j.1399-0004.2003.00106.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Standardizing CRISPR-Cas13 knockdown technique to investigate the role of cdh2 gene in pituitary development through growth hormone expression and transcription factors.
Front Endocrinol (Lausanne)
October 2024
Laboratory of Hormones and Molecular Genetics (LIM/42), Developmental Endocrinology Unit, Discipline of Endocrinology and Metabolism, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Introduction: Congenital hypopituitarism (CH) is characterized by the deficiency of pituitary hormones. Among CH patients, 85% lack a molecular diagnosis. Whole Exome Sequencing (WES) identified a homozygous variant (c.
View Article and Find Full Text PDFThe molecular basis of hypoprolactinaemia.
Rev Endocr Metab Disord
December 2024
Department of Paediatric Endocrinology, Great Ormond Street Children's Hospital, London, UK.
Hypoprolactinaemia is an endocrinopathy which is typically encountered as part of a combined pituitary hormone deficiency picture. The vast majority of genetic causes identified to date have been in the context of congenital hypopituitarism with multiple co-existent endocrinopathies. This is primarily with its closest hormonal relation, namely growth hormone.
View Article and Find Full Text PDFGNAS, not a Highly Mutated Gene, Has Prognostic Significance and Carcinogenic Effects in Osteosarcoma.
Cell Physiol Biochem
September 2024
Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai 201400, China,
Background/aims: Osteosarcoma is a prevalent and aggressive primary malignant bone tumor affecting children and adolescents. Despite advancements in sequencing technologies, there remains a lack of reliable prognostic biomarkers and effective targeted therapies for osteosarcoma. This study focuses on identifying key prognostic genes, particularly the role of GNAS, in osteosarcoma progression.
View Article and Find Full Text PDFGene Misexpression in a +ve/-Low Population in Juvenile -Mutant Pituitary Gland.
J Endocr Soc
August 2024
Department of Physiology & Biophysics, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
Article Synopsis
- * Researchers conducted single-cell RNA sequencing in mice to identify differences in gene expression between healthy and mutated pituitary cells, discovering a transitional cell state that may influence the development of endocrine cells.
- * The study found that the gene being overexpressed in mutant mice does not impact normal pituitary development, suggesting that the loss of Prophet of Pit-1 is not a direct cause of CPHD, prompting further investigation into the role of other upregulated genes in affected cells.
Etiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene.
Endocr Connect
October 2024
Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic.
Because the causes of combined pituitary hormone deficiency (CPHD) are complex, the etiology of congenital CPHD remains unknown in most cases. The aim of the study was to identify the genetic etiology of CPHD in a well-defined single-center cohort. In total, 34 children (12 girls) with congenital CPHD (growth hormone (GH) deficiency and impaired secretion of at least one other pituitary hormone) treated with GH in our center were enrolled in the study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!